We are on a mission to improve patient care with regenerative biomaterials that are inspired by nature.
Developing, manufacturing and commercializing regenerative acellular in-vitro grown “allograft” tissue.
TRUE to Nature™ Biomaterials
Announcing First in Human Use of TRUE™ Graft for Hemodialysis
Successful 6-month AV graft study in baboons
Naturally derived extracellular matrix
Predictable and tunable anisotropic tensile properties
Excellent post-implantation flow profiles of AV grafts in First in Human clinical study
Vascudyne Receives BioBusiness Award from Regenerative Medicine Minnesota for Treatment of Nerve Injury
Vascudyne Announces Presentation of First Clinical Results of TRUE AVC™ in Hemodialysis Access at the VASA Conference
Vascudyne’s CSO presents at the Heart Valve Society Meeting on tissue remodeling of engineered valved conduit evaluated at 52 weeks in the growing lamb
Copyright 2021 | Vascudyne, Inc.